Notice of Closed Meeting, 55291 [2020-19550]
Download as PDF
<![CDATA[
Federal Register / Vol. 85, No. 173 / Friday, September 4, 2020 / Notices
automated collection techniques or
other forms of information technology.
Obtaining Copies: Requesters may
obtain a copy of the information
collection documents from the GSA
Regulatory Secretariat Division by
calling 202–501–4755 or emailing
GSARegSec@gsa.gov.
Please cite OMB Control No. 9000–
0011, Preaward Survey Forms (Standard
Forms 1403, 1404, 1405, 1406, 1407,
and 1408).
William F. Clark,
Director, Office of Government-wide
Acquisition Policy, Office of Acquisition
Policy, Office of Government-wide Policy.
Operating Officer, Centers for Disease
Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit,
Office of the Chief Operating Officer, Centers
for Disease Control and Prevention.
[FR Doc. 2020–19550 Filed 9–3–20; 8:45 am]
BILLING CODE 4163–18–P
[FR Doc. 2020–19551 Filed 9–3–20; 8:45 am]
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
BILLING CODE 6820–EP–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Centers for Disease Control and
Prevention
Interagency Committee on Smoking
and Health (ICSH)
jbell on DSKJLSW7X2PROD with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended, and the Determination of
the Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, CDC, pursuant to
Public Law 92–463. The grant
applications and the discussions could
disclose confidential trade secrets or
commercial property such as patentable
material, and personal information
concerning individuals associated with
the grant applications, the disclosure of
which would constitute a clearly
unwarranted invasion of personal
privacy.
Name of Committee: Disease,
Disability, and Injury Prevention and
Control Special Emphasis Panel (SEP)—
PAR 15–352, Occupational Safety and
Health Training Project Grants (TPG).
Date: December 1–2, 2020.
Time: 8:00 a.m.–7:00 p.m., EST.
Place: Virtual Meeting.
Agenda: To review and evaluate grant
applications.
For Further Information Contact:
Marilyn Ridenour, B.S.N., M.P.H.,
Scientific Review Official, Office of
Extramural Programs, CDC, 1095
Willowdale Road, Morgantown, West
Virginia, 26505, Telephone: (304) 285–
5879; Email: MRidenour@cdc.gov.
The Director, Strategic Business
Initiatives Unit, Office of the Chief
VerDate Sep<11>2014
16:42 Sep 03, 2020
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice of meeting.
AGENCY:
Notice of Closed Meeting
Jkt 250001
In accordance with the
Federal Advisory Committee Act, the
Centers for Disease Control and
Prevention (CDC) announces the
following meeting of the Interagency
Committee on Smoking and Health
(ICSH). This is a virtual meeting and is
open to the public. The public is
welcome to view the meeting via Zoom,
limited only by the number of seats
available, which is 500. This meeting
will include time for members of the
public to make an oral comment.
Priority will be given to individuals
who submit a request to make an oral
public comment before the meeting
according to the procedures below.
DATES: The meeting will be held on
October 15, 2020 from 12:30 p.m. to
4:00 p.m., EDT.
ADDRESSES: Zoom Virtual Meeting. For
more information, including
information regarding registration and
login, please visit: https://www.cdc.gov/
tobacco/about/icsh/index.htm.
FOR FURTHER INFORMATION CONTACT:
Kathryn Gallagher, Alternate Designated
Federal Officer, MPH, Interagency
Committee on Smoking and Health,
CDC, 4770 Buford Highway NE, Atlanta,
Georgia 30341, telephone (404) 639–
6358; kgallagher@cdc.gov.
SUPPLEMENTARY INFORMATION:
Purpose: The Interagency Committee
on Smoking and Health shall provide
advice and guidance to the Secretary,
Department of Health and Human
SUMMARY:
PO 00000
Frm 00040
Fmt 4703
Sfmt 9990
55291
Services (HHS), regarding: (a)
Coordination of research, educational
programs, and other activities within
the Department that relate to the effect
of smoking on human health and on
coordination of these activities, with
similar activities of other Federal and
private agencies; and (b) establishment
and maintenance of liaisons with
appropriate private entities, other
Federal agencies, and State and local
public agencies, regarding activities
relating to the effect of cigarette smoking
on human health.
Matters to be considered: The agenda
will include discussions on the topic of
youth tobacco cessation. The meeting
objective is to identify federal actions to
prioritize areas of research that can be
expedited to support tobacco cessation
treatments for youth. Agenda items are
subject to change as priorities dictate.
Procedure for oral public comment:
All persons interested in making an oral
public comment at the October ICSH
meeting must submit an email request,
according to the instructions provided,
to Jade Chambers-Blair at OSHIM@
cdc.gov, no later than 11:59 p.m., EDT,
October 8, 2020. The email request
should include the speaker’s first and
last name, organization, address, phone,
and email. CDC will allow for as many
comments as permitted by time and will
queue individuals for comment in the
order in which their requests were
received. CDC staff will notify
individuals regarding their request to
speak by email by October 11, 2020. To
accommodate the interest in
participation in the oral public
comment session of ICSH meetings,
each speaker will be limited to 2
minutes, and each speaker may only
speak once per meeting.
For more information on ICSH please
visit the CDC.gov webpage: https://
www.cdc.gov/tobacco/about/icsh/
index.htm.
The Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease
Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit,
Office of the Chief Operating Officer, Centers
for Disease Control and Prevention.
[FR Doc. 2020–19642 Filed 9–3–20; 8:45 am]
BILLING CODE 4163–18–P
E:\FR\FM\04SEN1.SGM
04SEN1
]]>Agencies
[Federal Register Volume 85, Number 173 (Friday, September 4, 2020)]
[Notices]
[Page 55291]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-19550]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Notice of Closed Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended, and the Determination of the Director, Strategic
Business Initiatives Unit, Office of the Chief Operating Officer, CDC,
pursuant to Public Law 92-463. The grant applications and the
discussions could disclose confidential trade secrets or commercial
property such as patentable material, and personal information
concerning individuals associated with the grant applications, the
disclosure of which would constitute a clearly unwarranted invasion of
personal privacy.
Name of Committee: Disease, Disability, and Injury Prevention and
Control Special Emphasis Panel (SEP)--PAR 15-352, Occupational Safety
and Health Training Project Grants (TPG).
Date: December 1-2, 2020.
Time: 8:00 a.m.-7:00 p.m., EST.
Place: Virtual Meeting.
Agenda: To review and evaluate grant applications.
For Further Information Contact: Marilyn Ridenour, B.S.N., M.P.H.,
Scientific Review Official, Office of Extramural Programs, CDC, 1095
Willowdale Road, Morgantown, West Virginia, 26505, Telephone: (304)
285-5879; Email: [email protected].
The Director, Strategic Business Initiatives Unit, Office of the
Chief Operating Officer, Centers for Disease Control and Prevention,
has been delegated the authority to sign Federal Register notices
pertaining to announcements of meetings and other committee management
activities, for both the Centers for Disease Control and Prevention and
the Agency for Toxic Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2020-19550 Filed 9-3-20; 8:45 am]
BILLING CODE 4163-18-P
